Greater Freiburg Area
I work at the intersection of scientific, technical and human complexity — stabilizing systems that have become stuck and restoring clarity, structure and decision‑making capacity. With 20 years of experience in pharmaceutical development and high‑pressure project leadership (Roche, Idorsia, Carbogen‑Amcis, Corden Pharma), I bring teams, projects and cross‑functional interfaces back into a functional state — especially when timelines are tight, expectations high and communication strained. I work in the system and in the individual: I stabilize teams and projects operatively, and I use inner‑work methods only where they are systemically relevant — for example when mental patterns block collaboration, alignment or decision‑making. This hybrid competence allows me to resolve complexity at both levels and create momentum quickly. What I bring: • Structuring complex projects under uncertainty • Aligning scientific, technical and operational teams • De‑escalating conflicts and clarifying expectations • Stabilizing people in high‑pressure situations • Translating complexity into clear, actionable next steps • Restoring momentum in stalled or overloaded projects Where I create value: • Scientific Program Management • Research Operations & Coordination • Graduate Schools & Research Institutes • Cross‑functional Program Leadership • Mediation & Conflict Resolution • Interfaces between research, education and external partners I thrive in environments where competence matters more than hierarchy, where people care deeply about their work, and where clarity, integrity and meaningful progress are valued over appearances.
• Developed Egolysis™, an advanced evolution of Byron Katie’s The Work™, enabling searchers to achieve deep mental clarity. • Designed and launched the dedicated digital platform "Sorgenwaschanlage / The Worry Wash" from scratch to host and deliver these frameworks. • Delivered transformative workshops and tailored 1:1 guidance sessions. • Published the book "Die Sorgenwaschanlage" – Nov 2025. • Published the book "Nirvana. Bitte klingeln." – Apr 2026. • Integrated mindfulness, psychology, and cognitive analysis into a cohesive practice.
Leadership of multidisciplinary project teams for custom manufacturing of small molecule APIs, key intermediates & chiral building blocks for early and late phase clinical projects. Evaluation, initiation, execution, controlling until delivery and follow-up business. Primary point of contact for the customer Supervision and steering of timelines, quality and quantity Coaching of team members
Technical development leader for early and late phase clinical development of Drug Substance supplies. CMC leader for safeguarding early phase IMP supplies aligned with the overall project strategy. Key contributor to regulatory documents (IMPD, IND, IB) and health authority interactions (EOP2, NDA). CMC representative in Life Cycle teams and Due Diligence teams with insights into all aspects of drug development. Subject Matter Expert for supply of ADME and aBA clinical studies. -->Enabled scalability of a complex late phase Drug Substance synthesis, including polymorphic control, based on experience, creativity and by asking the right questions to the right people with a swift translation into action. --> Initiated and advanced extension of the commercial Drug Substance supply chain. --> Created Drug Substance control strategies, including in silico assessments, driven by diligence to detail and the bigger picture. --> Frequently provided support to peers with chemical challenges as well as with ADME/aBA clinical supplies, combining a fast perception with knowledge, motivated by the unsolved.
Technical lead and transfers of outsourced manufacturing steps of small molecule Drug Substances. Project Leadership at the interface of internal and external teams for early and late phase projects (single point of contact). Frequent member of Due Diligence teams assessing Drug Substance CMC part and the interface to Drug Product for new business opportunities. --> Developed a cost calculation tool to project and compare outsourcing activities globally. --> Drew up individually competitive syntheses in internal brainstorming sessions, e.g. for Alecensa®.
Responsible for the successful transfer and scale-up of laboratory processes to up to 4 m3 scale to supply Drug Substances for late phase clinical development. Team leader of global project teams ensuring a successful transfer, manufacture and usability in formulation and clinics. --> Took over responsibility as Deputy Plant Manager for safe and robust manufacturing processes and timely supplies of APIs and intermediates, e.g. for late development of Cotellic®. --> Facilitated workflow by pursuing a mediating function between plant, laboratories, engineering, quality assurance and formulation.